SCHOLAR ROCK SHARES UP 11.6% PREMARKET AFTER FDA NOD FOR FIRST MUSCLE-TARGETED DRUG FOR TYPE OF GENETIC DISEASE

Reuters · 3d ago

Please log in to view news